Literature DB >> 19744187

Anaplastic large cell lymphoma: a critical evaluation of cytomorphological features in seven cases.

P Das1, V K Iyer, S R Mathur, R Ray.   

Abstract

OBJECTIVE: Anaplastic large cell lymphoma (ALCL) is a rare subtype of non-Hodgkin's lymphoma that is difficult to diagnose on fine needle aspiration cytology (FNAC). Detailed descriptions about the cytomorphological features of ALCL are few and do not illustrate the various categories of cells, which we have done in this study.
METHODS: Eight FNAC specimens from seven patients with biopsy-proven ALCL over a period of 6 years were reviewed. Cytomorphological details were analysed and the various cell types identified were enumerated on Papanicolaou and May-Grünwald-Giemsa (MGG)-stained smears.
RESULTS: Of the seven cases, five were of conventional type, one of the lymphohistiocytic variant and one of the small cell variant. Aspiration from the conventional type showed a mixed population of lymphoid cells with many plasma cells. The tumour cells were intricately admixed within and distributed as single cells without grouping. Distinct hallmark cells, doughnut cells, embryo cells, tennis racket cells, cells with wreath-like nuclei, Reed-Sternberg-like cells and nondescript cells were seen. Nucleoli were rounded, occasionally tubular in shape. The tumour cells showed abundant blue cytoplasm on MGG stain with a perinuclear hoff. Aspiration from the lymphohistiocytic and small cell variants showed a small number of similar characteristic giant cells. All cases were confirmed as ALK-1 positive.
CONCLUSIONS: The morphological spectrum of ALCL is wide and it may be misdiagnosed as a metastatic poorly differentiated malignant tumour on FNAC. Identification of unusual giant cells on FNAC helps in establishing a diagnosis on an early lymph node biopsy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744187     DOI: 10.1111/j.1365-2303.2009.00675.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  8 in total

1.  Primary pulmonary anaplastic large cell lymphoma: case report and literature review.

Authors:  Weina Li; Fenggang Li; Jingxue Chu; Shuping Liu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-12-17       Impact factor: 0.196

Review 3.  Pediatric lymphoma diagnosis: role of FNAC, biopsy, immunohistochemistry and molecular diagnostics.

Authors:  Venkateswaran K Iyer
Journal:  Indian J Pediatr       Date:  2013-08-08       Impact factor: 1.967

4.  Anaplastic large cell lymphoma: The evolution continues.

Authors:  Dilip K Das
Journal:  J Cytol       Date:  2011-10       Impact factor: 1.000

5.  Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience.

Authors:  Nora K Frisch; Romil Nathan; Yasin K Ahmed; Vinod B Shidham
Journal:  Cytojournal       Date:  2014-04-29       Impact factor: 2.091

6.  Flow cytometric immunophenotyping and cell block immunocytochemistry in the diagnosis of primary Non-Hodgkin's Lymphoma by fine-needle aspiration: Experience from a tertiary care center.

Authors:  Tuhin Paul; Upasana Gautam; Arvind Rajwanshi; Ashim Das; Amita Trehan; Pankaj Malhotra; Radhika Srinivasan
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

7.  Anaplastic Lymphoma Kinase Immunocytochemistry in Fine Needle Aspiration Diagnosis of Anaplastic Large-cell Lymphoma.

Authors:  Prashant Ramteke; Sanjeev Chitragar; Ashok Singh; Saumyaranjan Mallick; Sandeep R Mathur; Deepali Jain; Venkateswaran K Iyer
Journal:  J Cytol       Date:  2018 Jan-Mar       Impact factor: 1.000

8.  Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.

Authors:  Dilip K Das
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.